191 related articles for article (PubMed ID: 33922533)
1. ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids.
Hedemann N; Herz A; Schiepanski JH; Dittrich J; Sebens S; Dempfle A; Feuerborn J; Rogmans C; Tribian N; Flörkemeier I; Weimer J; Krüger S; Maass N; Bauerschlag DO
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922533
[TBL] [Abstract][Full Text] [Related]
2. ADAM17 inhibition enhances platinum efficiency in ovarian cancer.
Hedemann N; Rogmans C; Sebens S; Wesch D; Reichert M; Schmidt-Arras D; Oberg HH; Pecks U; van Mackelenbergh M; Weimer J; Arnold N; Maass N; Bauerschlag DO
Oncotarget; 2018 Mar; 9(22):16043-16058. PubMed ID: 29662625
[TBL] [Abstract][Full Text] [Related]
3. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
[TBL] [Abstract][Full Text] [Related]
4. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
[TBL] [Abstract][Full Text] [Related]
5. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
Gunay G; Kirit HA; Kamatar A; Baghdasaryan O; Hamsici S; Acar H
Gynecol Oncol; 2020 Nov; 159(2):563-572. PubMed ID: 32958270
[TBL] [Abstract][Full Text] [Related]
6. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
7. Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.
Casagrande N; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Clin Cancer Res; 2014 Nov; 20(21):5496-506. PubMed ID: 25231401
[TBL] [Abstract][Full Text] [Related]
8. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
Casagrande N; Borghese C; Agostini F; Durante C; Mazzucato M; Colombatti A; Aldinucci D
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809553
[TBL] [Abstract][Full Text] [Related]
9. Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance.
Borghese C; Casagrande N; Corona G; Aldinucci D
Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32349462
[TBL] [Abstract][Full Text] [Related]
10. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.
El-Senduny FF; Badria FA; El-Waseef AM; Chauhan SC; Halaweish F
Tumour Biol; 2016 Jan; 37(1):685-98. PubMed ID: 26242260
[TBL] [Abstract][Full Text] [Related]
11. Three dimensional spheroid cell culture for nanoparticle safety testing.
Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
[TBL] [Abstract][Full Text] [Related]
12. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
[No Abstract] [Full Text] [Related]
13. Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors.
Chowanadisai W; Messerli SM; Miller DH; Medina JE; Hamilton JW; Messerli MA; Brodsky AS
PLoS One; 2016; 11(3):e0151089. PubMed ID: 26986722
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture.
Aughton K; Shahidipour H; Djirackor L; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2020 Jun; 9(7):39. PubMed ID: 32832244
[TBL] [Abstract][Full Text] [Related]
15. Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.
Fabbi M; Costa D; Russo D; Arenare L; Gaggero G; Signoriello S; Scambia G; Pisano C; Colombo N; Losito NS; Filaci G; Spina A; Califano D; Scognamiglio G; Gadducci A; Mezzanzanica D; Bagnoli M; Ferrini S; Canzonieri V; Chiodini P; Perrone F; Pignata S
Diagnostics (Basel); 2022 Aug; 12(9):. PubMed ID: 36140519
[TBL] [Abstract][Full Text] [Related]
16. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T
Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246
[TBL] [Abstract][Full Text] [Related]
17. Stable Isotope-Resolved Metabolomics Shows Metabolic Resistance to Anti-Cancer Selenite in 3D Spheroids versus 2D Cell Cultures.
Fan TW; El-Amouri SS; Macedo JKA; Wang QJ; Song H; Cassel T; Lane AN
Metabolites; 2018 Jul; 8(3):. PubMed ID: 29996515
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics.
Thakuri PS; Gupta M; Plaster M; Tavana H
Assay Drug Dev Technol; 2019 Apr; 17(3):140-149. PubMed ID: 30958703
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferation activity of Devil's club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids.
Tai J; Cheung SS; Ou D; Warnock GL; Hasman D
Phytomedicine; 2014 Mar; 21(4):506-14. PubMed ID: 24215675
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-, Doxorubicin-, and Docetaxel-Induced Cell Death Promoted by the Aqueous Extract of Solanum nigrum in Human Ovarian Carcinoma Cells.
Wang CW; Chen CL; Wang CK; Chang YJ; Jian JY; Lin CS; Tai CJ; Tai CJ
Integr Cancer Ther; 2015 Nov; 14(6):546-55. PubMed ID: 26069278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
